Clinical Trials
Pfizer Phase 3 fibromyalgia study of pregabalin meets primary...
Pfizer Phase III study of pregabalin controlled-release (CR) formulation has met primary endpoint of time to loss of therapeutic response (LTR), in fibromyalgia patients....
Clinical Trials
Idera completes patient enrollment in Phase 2 trial of...
Idera Pharmaceuticals has concluded enrolling patients in double-blind, placebo-controlled Phase 2 trial assessing IMO-3100 in psoriasis patients. The study randomized...
Clinical Trials
Novavax pandemic influenza vaccine meets endpoints in two Phase...
Novavax A/H5N1 avian influenza vaccine candidate has met safety and immunogenicity endpoints in two Phase 1 clinical trials. The trials...
Clinical Trials
Hybrigenics starts phase II clinical trial of inecalcitol in...
Hybrigenics (ALHYG), a bio-pharmaceutical company listed on Alternext (NYSE-Euronext) in Paris, with a focus on research and development of new treatments against proliferative diseases,...
Clinical Trials
Millennium begins pharmacogenetics clinical outcomes study
Millennium Laboratories has commenced clinical outcomes study of its pharmacogenetic test. As part of the study, Millennium will evaluate the...
Clinical Trials
PhaseBio initiates Phase 2b trial of Glymera
PhaseBio Pharmaceuticals has commenced patient dosing in a multicenter Phase 2b trial designed to evaluate the efficacy and safety of three doses of once...
Clinical Trials
Medistem announces initiation of critical limb ischemia study
Medistem and Shanghai Jia Fu Medical Apparatus have announced the initiation of critical limb ischemia study by treating first two patients with Endometrial Regenerative...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.